T&L Biotechnology
Private Company
Funding information not available
Overview
T&L Biotechnology is a private, revenue-generating supplier of critical raw materials and services to the rapidly growing cell and gene therapy industry. Operating as a platform and services company, it provides GMP-grade reagents like cytokines, antibodies, and magnetic beads, alongside custom services such as protein expression and CAR-NK cell therapy development. With a global distributor network and a focus on upstream CGT processes, the company positions itself as an essential partner for biopharma and research institutions advancing next-generation therapies.
Technology Platform
Integrated platform for GMP-grade recombinant protein production, monoclonal antibody development, magnetic bead-based cell separation, and serum-free cell culture media formulation for cell and gene therapy applications.
Opportunities
Risk Factors
Competitive Landscape
T&L competes in the life science reagents and tools market, which is dominated by global giants like Thermo Fisher Scientific, Merck KGaA, and Sartorius. Its differentiation lies in its specific focus on GMP-grade materials for CGT, a niche where it competes with other specialized suppliers and CDMOs offering process development services. Success hinges on superior product quality, customer service, and technical expertise in a crowded field.